Skip to main content

HRT FINANCIAL LP

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1475597 NEW YORK, NY

Position in HALO

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$11,279,809
-$6,362,641 QoQ
Shares Held
174,529
-27.4% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $422,126,766 across 199 Biotechnology names. HALO ranks #10 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,279,809 174,529
2025-09-30 $17,642,450 240,557
2025-06-30 $24,296,981 467,070
2025-03-31 $4,408,313 69,085
2024-06-30 $479,355 9,155
2023-12-31 $2,894,633 78,318
2023-09-30 $3,129,878 81,934
2023-06-30 $1,147,278 31,807
2023-03-31 $2,811,891 73,629
2022-12-31 $3,559,777 62,562
2022-09-30 $701,637 17,745
2022-06-30 $3,448,456 78,374
2021-12-31 $1,429,344 35,547
2021-03-31 $879,325 21,092